NewYork-Presbyterian has adopted Signal 1's AI Management System to govern every AI tool across the hospital network under one oversight platform, reflecting a shift from vetting individual AI products to managing a growing portfolio of predictive, generative, and agentic AI tools.
NHS England South East is rolling out Skin Analytics' DERM AI tool across all 18 regional hospital trusts, its largest autonomous-AI deployment to date, reaching about nine million more people. The system can discharge patients with benign lesions without a specialist visit, but regulators have kept its NHS approval conditional while more evidence is gathered.
A Mount Sinai-led study published in Nature Medicine found ChatGPT Health under-triaged 52% of true medical emergencies, including cases of diabetic ketoacidosis and impending respiratory failure. OpenAI disputes the study's real-world relevance, while outside physicians say the tool isn't yet reliable enough for urgent-care decisions.
GE HealthCare and Mass General Brigham announced a research collaboration on September 23, 2026 to explore generative AI that helps radiation oncology teams navigate scattered treatment records. The project builds on earlier MGH software that GE says cut treatment start times from 30 days to eight at one hospital.
Rome's Sant'Andrea University Hospital routed nearly 5,700 emergency ECGs through Powerful Medical's Queen of Hearts AI over six months, catching STEMI-equivalent heart attacks that standard criteria often miss and alerting cardiologists in under 17 seconds. The case study, released October 7, 2026, comes as the AI also gains FDA authorization and expands into prehospital ambulance care.
Healthleap, a startup that uses AI to mine hospital notes and flag malnourished and otherwise undiagnosed patients, has raised $38 million from Sequoia Capital, First Round Capital, and Hummingbird Ventures, as it expands from 50 hospitals toward a roadmap of more than 40 conditions.
Clairity Breast, an FDA-authorized AI tool that reads mammograms to predict five-year breast cancer risk, launched nationwide direct-to-consumer through Everlywell on October 1, 2026, bypassing the traditional physician-and-insurer pipeline. STAT News examined the move as part of its 'Paying for AI' series on the costs and tradeoffs of consumer-facing clinical AI.
Twelve major U.S. health systems, including Cedars-Sinai, Mount Sinai, and Houston Methodist, have formed the Diagnostic AI Consortium with Aidoc to standardize how AI-assisted diagnosis is deployed and governed amid a worsening radiologist shortage. The group plans to publish shared evidence and governance practices starting in 2027.
UpDoc has announced FDA clearance for software that gives type 2 diabetes patients insulin dosing instructions through a conversational interface, a device the FDA record shows was cleared in December 2025 as a bounded, physician-configured insulin calculator rather than an autonomous AI doctor.
Medidata's second annual survey of pharmaceutical trial sponsors found experienced AI adopters report faster timelines and fewer protocol deviations, but most of the industry says AI has yet to meet expectations, with gains so far concentrated in routine administrative workflows.